Clinical trial
Optimizing Extended Adjuvant Endocrine Therapy in Patients With Breast Cancer
NCT06223698
Study timeline
Study start (estimated)2025-05-02Date precision: day
Registry last updated2025-04-20
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Breast Cancerunresolved
Interventions
LetrozoleDRUG · verified · RxNorm: letrozole
AnastrozoleDRUG · verified · RxNorm: anastrozole
ExemestaneDRUG · verified · RxNorm: exemestane
TamoxifenDRUG · verified · RxNorm: tamoxifen
Sponsors & collaborators
Region Örebro Countylead sponsor
Mid-Sweden Regional Cancer Centrecollaborator
Uppsala University Hospitalcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06223698 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.